XML 110 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value of Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2014
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following table presents information about the Company’s assets and liabilities (including derivatives that are presented net) measured at fair value on a recurring basis as of March 31, 2014 and December 31, 2013, aggregated by the level in the fair value hierarchy within which those instruments fall (in thousands):


Quoted Prices
in Active
Markets
Level 1

Significant Other
Observable
Inputs
Level 2

Significant
Unobservable
Inputs
Level 3

Balance as of
March 31, 2014
Assets:








Investments in real estate fund
 
$

 
$
1,648

 
$

 
$
1,648

CMBS
 

 

 
212,155

 
212,155

Interest rate swap assets


 
9,829

 


9,829

Total assets
 
$

 
$
11,477

 
$
212,155

 
$
223,632

Liabilities:
 
 
 
 
 
 
 
 
Interest rate swap liabilities

$

 
$
(8,737
)
 
$


$
(8,737
)
Series D Preferred Stock embedded derivative


 

 
(26,734
)

(26,734
)
Contingent consideration arrangements
 

 

 
(4,903
)
 
(4,903
)
Total liabilities

$


$
(8,737
)

$
(31,637
)

$
(40,374
)









 
 
 
 
 
 
 
 
 


Quoted Prices
in Active
Markets
Level 1

Significant Other
Observable
Inputs
Level 2

Significant
Unobservable
Inputs
Level 3

Balance as of December 31, 2013
Assets:
 
 
 
 
 
 
 
 
Investments in real estate fund
 
$

 
$
1,484

 
$

 
$
1,484

CMBS
 

 

 
60,583

 
60,583

Interest rate swap assets
 

 
9,189

 

 
9,189

Total assets
 
$

 
$
10,673

 
$
60,583

 
$
71,256

Liabilities:
 
 
 
 
 
 
 
 
Interest rate swap liabilities
 
$

 
$
(1,719
)
 
$

 
$
(1,719
)
Series D Preferred Stock embedded derivative
 

 

 
(16,736
)
 
(16,736
)
Total liabilities
 
$

 
$
(1,719
)
 
$
(16,736
)
 
$
(18,455
)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
The following is a reconciliation of the beginning and ending balance for the changes in instruments with Level 3 inputs in the fair value hierarchy for the three months ended March 31, 2014 (in thousands):
 
 
CMBS
 
Series D Preferred Stock Embedded Derivative
 
Contingent Consideration
Arrangements
 
Total
Beginning Balance as of December 31, 2013
 
$
60,583

 
$
(16,736
)
 
$

 
$
43,847

Total gains and losses:
 
 
 
 
 
 
 
 
Unrealized gain included in other comprehensive income, net
 
2,948

 

 

 
2,948

Changes in fair value included in net income, net
 

 
(9,998
)
 
(1,297
)
 
(11,295
)
Purchases, issuances, settlements and amortization:
 
 
 
 
 
 
 
 
Purchases/issuances
 
151,197

 

 
(3,606
)
 
147,591

Amortization included in net income, net
 
(2,573
)
 
$

 

 
(2,573
)
Ending balance as of March 31, 2014
 
$
212,155

 
$
(26,734
)
 
$
(4,903
)
 
$
180,518

Fair Value, by Balance Sheet Grouping
The fair values of the Company’s financial instruments that are not reported at fair value on the consolidated balance sheets are reported below (dollar amounts in thousands):
 
 
 
 
Carrying Amount at
 
Fair Value at
 
Carrying Amount at
 
Fair Value at
 
 
Level
 
March 31, 2014
 
March 31, 2014
 
December 31, 2013
 
December 31, 2013
Assets:
 
 
 
 
 
 
 
 
 
 
Loans held for investment
 
3
 
$
98,185

 
$
98,652

 
$
26,279

 
$
26,435

 
 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
Mortgage notes payable, net
 
3
 
$
4,234,668

 
$
4,265,230

 
$
1,301,114

 
$
1,305,823

Corporate bonds, net
 
3
 
$
2,545,884

 
$
2,545,884

 
$

 
$

Convertible debt, net
 
3
 
$
973,737

 
$
976,629

 
$
972,490

 
$
976,629

Senior corporate credit facility
 
3
 
2,265,800

 
2,265,800

 
1,819,800

 
1,819,800

Secured term loan
 
3
 
53,958

 
54,035

 
58,979

 
59,049

Trust preferred notes
 
3
 
26,563

 
23,485

 
26,548

 
23,345

Unsecured credit facility
 
3
 
150,000

 
150,000

 
150,000

 
150,000

Other debt
 
3
 
68,288

 
68,414

 
19,278

 
19,350

Total liabilities
 
 
 
$
10,318,898

 
$
10,349,477

 
$
4,348,209

 
$
4,353,996